Observational study on managing infants with congenital CMV
Official title: Observational Study of the Management of Infants With Congenital CMV
Run by St George's, University of London · NCT05855889 · Data updated 2026-11-12
This study is tracking infants with congenital cytomegalovirus to see how their health develops over time and to improve future care for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 10 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | St George's, University of London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | March 9, 2023 |
| Main results expected | March 30, 2031 |
| Study ends | March 30, 2038 |
| Registry record updated | May 23, 2023 |
| Trial ID | NCT05855889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include infants diagnosed with cCMV infection through specific laboratory methods within the first 21 days of life.
✕Probably not a fit
Patients who do not have a confirmed diagnosis of cCMV or whose parents do not consent to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on infants diagnosed with congenital cytomegalovirus (cCMV) through a multicenter cohort approach. It will track these patients from various clinical perspectives, including infectious diseases, audiology, ophthalmology, and neurodevelopment, until they are approximately six years old. The study will not involve any additional investigations or treatments beyond standard clinical practice, and it will also include some children diagnosed retrospectively. The goal is to identify characteristics associated with patient outcomes to enhance future care.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for infants with congenital CMV.
How similar studies have gone: Other studies have shown success in understanding cCMV management, but this specific observational approach may provide novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients of either sex that have been diagnosed with cCMV infection: * Through confirmed detection of CMV in urine or saliva, by CMV-DNA PCR (or viral culture / Shell-vial) and/or CMV detection in blood or CSF by PCR within the first 21 days of life. * Children with cCMV retrospectively diagnosis by positive CMV-DNA PCR in dried blood spots (DBS), collected within 21 days of life. * Diagnosed by positive CMV-DNA PCR in dried umbilical cord blood or donated/stored umbilical cord blood sample * Children whose parents give their informed consent to participate in the study * Age less than 11 years old Exclusion Criteria: * Refusal to sign written informed consent of parents/ legal guardian.
Where it's running
-
St George's University of London
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Simon Drysdale, MD — St George's, University of London
- Study coordinator: Sana Ibrahim, BSc
- Email: sibrahim@sgul.ac.uk
- Phone: +44 (0)208 725 5382
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multiplex immunoassay quality panel for Group B Strep antibodies
This project will collect one blood sample from women who received the GBS6 vaccine during pregnancy and are HIV-negative to create quality-control samples for a lab test that measures Group B Strep antibodies.
-
Family involvement in treatment decisions for very old ICU patients
This study observes how families and ICU teams communicate with patients 75 and older to see how family meetings affect planning and care.
-
Database for tracking neonatal infections
This study is creating a system to track and understand bacterial infections in newborns in the UK to help doctors respond quickly and improve care.
-
Surgical procedure to improve outcomes after spinal cord injury
This study is testing if a new surgery that adds a patch to relieve pressure on the spinal cord can help adults with severe spinal cord injuries get stronger and improve their quality of life compared to standard surgery alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.